McIlrath & Eck’s Synovus SNV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-71
| Closed | -$3.55K | – | 1691 |
|
|
2025
Q4 | $3.55K | Sell |
71
-472
| -87% | -$22.7K | ﹤0.01% | 822 |
|
|
2025
Q3 | $26.6K | Buy |
543
+472
| +665% | +$24.2K | ﹤0.01% | 444 |
|
|
2025
Q2 | $3.67K | Sell |
71
-1,742
| -96% | -$80.1K | ﹤0.01% | 766 |
|
|
2025
Q1 | $84.7K | Buy |
1,813
+1,428
| +371% | +$73.7K | 0.01% | 223 |
|
|
2024
Q4 | $19.7K | Hold |
385
| – | – | ﹤0.01% | 485 |
|
|
2024
Q3 | $17.1K | Hold |
385
| – | – | ﹤0.01% | 503 |
|
|
2024
Q2 | $15.5K | Hold |
385
| – | – | ﹤0.01% | 511 |
|
|
2024
Q1 | $15.4K | Hold |
385
| – | – | ﹤0.01% | 521 |
|
|
2023
Q4 | $14.5K | Hold |
385
| – | – | ﹤0.01% | 474 |
|
|
2023
Q3 | $10.7K | Hold |
385
| – | – | ﹤0.01% | 537 |
|
|
2023
Q2 | $11.6K | Hold |
385
| – | – | ﹤0.01% | 541 |
|
|
2023
Q1 | $11.9K | Hold |
385
| – | – | ﹤0.01% | 525 |
|
|
2022
Q4 | $14.5K | Hold |
385
| – | – | ﹤0.01% | 465 |
|
|
2022
Q3 | $14K | Hold |
385
| – | – | ﹤0.01% | 467 |
|
|
2022
Q2 | $14K | Hold |
385
| – | – | ﹤0.01% | 451 |
|
|
2022
Q1 | $19K | Hold |
385
| – | – | 0.01% | 410 |
|
|
2021
Q4 | $18K | Hold |
385
| – | – | ﹤0.01% | 428 |
|
|
2021
Q3 | $17K | Hold |
385
| – | – | 0.01% | 425 |
|
|
2021
Q2 | $17K | Hold |
385
| – | – | 0.01% | 422 |
|
|
2021
Q1 | $18K | Hold |
385
| – | – | 0.01% | 364 |
|
|
2020
Q4 | $12K | Sell |
385
-128
| -25% | -$3.7K | ﹤0.01% | 390 |
|
|
2020
Q3 | $11K | Hold |
513
| – | – | ﹤0.01% | 364 |
|
|
2020
Q2 | $11K | Hold |
513
| – | – | 0.01% | 340 |
|
|
2020
Q1 | $9K | Hold |
513
| – | – | 0.01% | 327 |
|
|
2019
Q4 | $20K | Hold |
513
| – | – | 0.01% | 243 |
|
|
2019
Q3 | $18K | Hold |
513
| – | – | 0.01% | 237 |
|
|
2019
Q2 | $18K | Hold |
513
| – | – | 0.01% | 216 |
|
|
2019
Q1 | $18K | Buy |
+513
| New | +$18.8K | 0.01% | 216 |
|
Other funds holding SNV
McIlrath & Eck's SNV Position: Q1 2026 in Review
McIlrath & Eck sold out of Synovus (SNV) in Q1 2026, closing a stake of 71 shares — an estimated $3.55K sold.
McIlrath & Eck first reported a position in SNV in Q1 2019 and held it in 28 quarters. The position peaked at $84.7K in Q1 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.
- McIlrath & Eck reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
- McIlrath & Eck sold 71 Synovus shares in Q1 2026, an estimated $3.55K.
- McIlrath & Eck first reported a position in Synovus in Q1 2019 and held it in 28 quarters.
- McIlrath & Eck's Synovus position peaked at $84.7K in Q1 2025.
- 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.
Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.